Cycloferon® (Meglumine Acridonacetate) 150 mg x 10 Coated Tablets
- $14.30
Out Of Stock
Cycloferon® is a low molecular weight interferon inducer, which determines a wide range of its biological activity (antiviral, immunomodulatory, anti-inflammatory, etc.).
Cycloferon® is effective against tick-borne encephalitis, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus, papilloma virus and other viruses. In acute viral hepatitis, Cycloferon prevents the transition of diseases to a chronic form.
Other brand names: Antimania, Arachidonic acid, Bilisegrol, Chologram, Cridanimod, Fluisedal, Glucantrix, Méglumine
One tablet contains: active ingredient - meglumine acridone acetate in terms of acridoneacetic acid - 150.00 mg, obtained according to the following recipe:
acridoneacetic acid - 150.00 mg, meglumine (N-methylglucamine) - 146.00 mg;
excipients: povidone K 30 - 7.93 mg, calcium stearate - 3.07 mg, hypromellose - 2.73 mg, polysorbate 80 - 0.27 mg;
enteric coating: methacrylic acid and ethyl acrylate copolymer
- 23.21 mg, propylene glycol - 1.79 mg.
In adults in complex therapy:
In children from the age of four in complex therapy:
In children from the age of four for the prevention of influenza and acute respiratory diseases.
Pregnancy, breastfeeding period, children under 4 years of age (due to imperfect swallowing), individual intolerance to the components of the drug, decompensated liver cirrhosis.
Take Cycloferon with care:
In case of diseases of the digestive system in the stage of exacerbation (erosion, stomach and / or duodenal ulcers, gastritis and duodenitis) and allergic reactions in history, before taking the drug, be sure to consult with your doctor.
DURING PREGNANCY AND DURING BREASTFEEDING
The use of the drug during pregnancy and during breastfeeding is contraindicated.
Inside, once a day, 30 minutes before meals, without chewing, drinking ½ glass of water, in age dosages:
children 4–6 years old: 150 mg (1 tablet) per dose;
children 7-11 years old: 300-450 mg (2-3 tablets) per appointment;
adults and children over 12 years old: 450-600 mg (3-4 tablets) per dose.
It is advisable to repeat the course 2-3 weeks after the end of the first course.
In adults:
In the treatment of influenza and acute respiratory diseases, the drug is taken on the 1st, 2nd, 4th, 6th, 8th day (the course of treatment is 20 tablets). Treatment should be started at the first symptoms of the disease.
For severe flu, six tablets are taken on the first day. If necessary, symptomatic therapy is additionally carried out (antipyretic, analgesic, expectorant drugs).
In case of herpes infection, the drug is taken for 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days (course of treatment - 40 tablets). Treatment is most effective when the first symptoms of the disease appear.
In children from the age of four:
In case of influenza and acute respiratory diseases, the drug is taken in age doses on days 1, 2, 4, 6, 8, 11, 14, 17, 20, 23. The course of treatment is from 5 to 10 doses, depending on the severity of the condition and the severity of clinical symptoms.
In case of herpes infection, the drug is taken on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th day of treatment. The course of treatment may vary depending on the severity of the condition and the severity of the clinical symptoms.
For urgent non-specific prophylaxis of influenza and acute respiratory diseases (with direct contact with patients with influenza or acute respiratory infections of a different etiology, during an influenza epidemic): on the 1st, 2nd, 4th, 6th, 8th day. Then take a break of 72 hours (three days) and continue the course for 11, 14, 17, 20, 23 days. The general course is from 5 to 10 receptions.
According to the World Health Organization, adverse effects are classified according to the frequency of their development as follows:
- very frequent (≥ 1/10);
- frequent (≥ 1/100 - <1/10);
- infrequent (≥ 1/1000 - <1/100);
- rare (≥ 1/10000 - <1/1000);
- very rare (<1/10000);
- the frequency is unknown (cannot be determined from the available data).
Immune system disorders: very rarely - angioedema.
Violations of the skin and subcutaneous tissues: very rarely - rash, urticaria.
If any of the undesirable effects indicated in the instructions are aggravated or you notice any other undesirable effects that are not indicated in the instructions, inform your doctor.
There is no information on drug overdose.
Cycloferon is compatible with all drugs used in the treatment of these diseases (interferons, chemotherapeutic, symptomatic drugs, etc.). Enhances the action of interferons and nucleoside analogs. Reduces the side effects of chemotherapy, interferon therapy.
Cycloferon does not affect the ability to drive vehicles.
In case of diseases of the thyroid gland, it is necessary to consult an endocrinologist.
If the next dose of the drug is missed, then at the first opportunity, without taking into account the time interval and doubling the dosage, continue the course according to the begun scheme.
In the absence of a therapeutic effect, you must consult a doctor.
In a dark place at a temperature not exceeding 25 ° C. Keep out of the reach of children.
Shelf life 2 years.
Do not use after the expiration date printed on the package.
Cycloferon® is effective against tick-borne encephalitis, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus, papilloma virus and other viruses. In acute viral hepatitis, Cycloferon prevents the transition of diseases to a chronic form.
Other brand names: Antimania, Arachidonic acid, Bilisegrol, Chologram, Cridanimod, Fluisedal, Glucantrix, Méglumine
The composition of Cycloferon tablets
One tablet contains: active ingredient - meglumine acridone acetate in terms of acridoneacetic acid - 150.00 mg, obtained according to the following recipe:
acridoneacetic acid - 150.00 mg, meglumine (N-methylglucamine) - 146.00 mg;
excipients: povidone K 30 - 7.93 mg, calcium stearate - 3.07 mg, hypromellose - 2.73 mg, polysorbate 80 - 0.27 mg;
enteric coating: methacrylic acid and ethyl acrylate copolymer
- 23.21 mg, propylene glycol - 1.79 mg.
Indications for the use of Cycloferon tablets
In adults in complex therapy:
- flu and acute respiratory infections
- herpes infection
In children from the age of four in complex therapy:
- flu and acute respiratory infections
- herpes infection
In children from the age of four for the prevention of influenza and acute respiratory diseases.
CONTRAINDICATIONS
Pregnancy, breastfeeding period, children under 4 years of age (due to imperfect swallowing), individual intolerance to the components of the drug, decompensated liver cirrhosis.
Take Cycloferon with care:
In case of diseases of the digestive system in the stage of exacerbation (erosion, stomach and / or duodenal ulcers, gastritis and duodenitis) and allergic reactions in history, before taking the drug, be sure to consult with your doctor.
DURING PREGNANCY AND DURING BREASTFEEDING
The use of the drug during pregnancy and during breastfeeding is contraindicated.
METHODS OF APPLICATION AND DOSES
Inside, once a day, 30 minutes before meals, without chewing, drinking ½ glass of water, in age dosages:
children 4–6 years old: 150 mg (1 tablet) per dose;
children 7-11 years old: 300-450 mg (2-3 tablets) per appointment;
adults and children over 12 years old: 450-600 mg (3-4 tablets) per dose.
It is advisable to repeat the course 2-3 weeks after the end of the first course.
In adults:
In the treatment of influenza and acute respiratory diseases, the drug is taken on the 1st, 2nd, 4th, 6th, 8th day (the course of treatment is 20 tablets). Treatment should be started at the first symptoms of the disease.
For severe flu, six tablets are taken on the first day. If necessary, symptomatic therapy is additionally carried out (antipyretic, analgesic, expectorant drugs).
In case of herpes infection, the drug is taken for 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days (course of treatment - 40 tablets). Treatment is most effective when the first symptoms of the disease appear.
In children from the age of four:
In case of influenza and acute respiratory diseases, the drug is taken in age doses on days 1, 2, 4, 6, 8, 11, 14, 17, 20, 23. The course of treatment is from 5 to 10 doses, depending on the severity of the condition and the severity of clinical symptoms.
In case of herpes infection, the drug is taken on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th day of treatment. The course of treatment may vary depending on the severity of the condition and the severity of the clinical symptoms.
For urgent non-specific prophylaxis of influenza and acute respiratory diseases (with direct contact with patients with influenza or acute respiratory infections of a different etiology, during an influenza epidemic): on the 1st, 2nd, 4th, 6th, 8th day. Then take a break of 72 hours (three days) and continue the course for 11, 14, 17, 20, 23 days. The general course is from 5 to 10 receptions.
Possible side effects
According to the World Health Organization, adverse effects are classified according to the frequency of their development as follows:
- very frequent (≥ 1/10);
- frequent (≥ 1/100 - <1/10);
- infrequent (≥ 1/1000 - <1/100);
- rare (≥ 1/10000 - <1/1000);
- very rare (<1/10000);
- the frequency is unknown (cannot be determined from the available data).
Immune system disorders: very rarely - angioedema.
Violations of the skin and subcutaneous tissues: very rarely - rash, urticaria.
If any of the undesirable effects indicated in the instructions are aggravated or you notice any other undesirable effects that are not indicated in the instructions, inform your doctor.
OVERDOSE
There is no information on drug overdose.
INTERACTION WITH OTHER DRUGS
Cycloferon is compatible with all drugs used in the treatment of these diseases (interferons, chemotherapeutic, symptomatic drugs, etc.). Enhances the action of interferons and nucleoside analogs. Reduces the side effects of chemotherapy, interferon therapy.
SPECIAL INSTRUCTIONS
Cycloferon does not affect the ability to drive vehicles.
In case of diseases of the thyroid gland, it is necessary to consult an endocrinologist.
If the next dose of the drug is missed, then at the first opportunity, without taking into account the time interval and doubling the dosage, continue the course according to the begun scheme.
In the absence of a therapeutic effect, you must consult a doctor.
STORAGE CONDITIONS
In a dark place at a temperature not exceeding 25 ° C. Keep out of the reach of children.
Shelf life 2 years.
Do not use after the expiration date printed on the package.
Related Products
